Eye-Bleeding Virus Outbreak Claims Nine Lives: Urgent Health Advisory
A recent outbreak of the Marburg virus, often referred to as the “eye-bleeding” disease due to its severe hemorrhagic symptoms, has resulted in nine fatalities in Tanzania’s Kagera region. The World Health Organization (WHO) has confirmed ten cases in this area.
Marburg virus disease (MVD) is a severe hemorrhagic fever caused by the Marburg virus, a member of the same family as the Ebola virus. The disease has a case fatality ratio of up to 88%, but it can be much lower with good and early patient care.
Transmission occurs through direct contact with the bodily fluids of infected individuals or animals, as well as contact with surfaces and materials contaminated with these fluids. The virus can also spread through contact with infected fruit bats, which are considered natural hosts.
Symptoms of MVD include high fever, severe headache, muscle pains, and profound weakness, progressing to severe hemorrhagic manifestations such as bleeding from the eyes, nose, and gums. Currently, there is no specific treatment or vaccine for MVD; however, early supportive care, including rehydration and symptomatic treatment, can improve survival rates.
In response to the outbreak, the WHO is collaborating with Tanzanian health authorities to implement measures aimed at containing the virus’s spread. Efforts include contact tracing, public health education, and the provision of medical support to affected individuals.
Health experts emphasize the importance of early detection and isolation of cases, adherence to infection prevention and control measures, and public awareness to prevent further transmission. The situation is being closely monitored, and updates will be provided as more information becomes available.